Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of Lophius Kits T-Track® CMV and T-Track® EBV to Assess the Functionality of Cell-mediated Immunity (CMI) in Hemodialysis Patients

NCT02630537 is registered in ClinicalTrials.gov with Lophius Biosciences GmbH as lead sponsor.

NCT NCT02630537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02630537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of Lophius Kits T-Track® CMV and T-Track® EBV to Assess the Functionality of Cell-mediated Immunity (CMI) in Hemodialysis Patients
Lead sponsor
Lophius Biosciences GmbH
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
September 30, 2012
Enrollment
133 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure chronic requiring dialysis